BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16157293)

  • 1. Indoleamine 2,3 dioxygenase and regulation of T cell immunity.
    Mellor A
    Biochem Biophys Res Commun; 2005 Dec; 338(1):20-4. PubMed ID: 16157293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tryptophan catabolism in acquisition and effector function of memory T cells.
    Dai H; Dai Z
    Curr Opin Organ Transplant; 2008 Feb; 13(1):31-5. PubMed ID: 18660704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
    Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
    Orabona C; Grohmann U
    Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of indoleamine 2,3-dioxygenase on transplantation immunity].
    Duan X; Cui P; Jiang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):230-3. PubMed ID: 18365624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
    Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
    Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
    Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
    Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
    Puccetti P; Fallarino F
    Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoregulatory role of IDO-producing human dendritic cells revisited.
    Terness P; Chuang JJ; Opelz G
    Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
    Di Pucchio T; Danese S; De Cristofaro R; Rutella S
    Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
    Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.
    Liu H; Liu L; Liu K; Bizargity P; Hancock WW; Visner GA
    J Immunol; 2009 Jul; 183(2):1022-31. PubMed ID: 19564344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
    Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
    Wound Repair Regen; 2008; 16(3):379-87. PubMed ID: 18471256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.
    Mellor AL; Munn DH
    Semin Immunol; 2001 Aug; 13(4):213-8. PubMed ID: 11437628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
    Witkiewicz A; Williams TK; Cozzitorto J; Durkan B; Showalter SL; Yeo CJ; Brody JR
    J Am Coll Surg; 2008 May; 206(5):849-54; discussion 854-6. PubMed ID: 18471709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.